ZA948169B - Peptidyl derivatives and processes for their preparation - Google Patents

Peptidyl derivatives and processes for their preparation

Info

Publication number
ZA948169B
ZA948169B ZA948169A ZA948169A ZA948169B ZA 948169 B ZA948169 B ZA 948169B ZA 948169 A ZA948169 A ZA 948169A ZA 948169 A ZA948169 A ZA 948169A ZA 948169 B ZA948169 B ZA 948169B
Authority
ZA
South Africa
Prior art keywords
pct
derivatives
processes
preparation
sec
Prior art date
Application number
ZA948169A
Other languages
English (en)
Inventor
John Richard Morphy
Thomas Andrew Millicam
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939308696A external-priority patent/GB9308696D0/en
Priority to DE69419473T priority Critical patent/DE69419473T2/de
Priority to EP94913709A priority patent/EP0648205B1/fr
Priority to PCT/GB1994/000895 priority patent/WO1994025434A1/fr
Priority to AU65753/94A priority patent/AU6575394A/en
Priority to AT94913709T priority patent/ATE182137T1/de
Priority to ES94913709T priority patent/ES2134939T3/es
Priority to CA002139128A priority patent/CA2139128A1/fr
Priority to US08/356,315 priority patent/US5714491A/en
Priority to JP6524026A priority patent/JPH08500124A/ja
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Priority to ZA948169A priority patent/ZA948169B/xx
Publication of ZA948169B publication Critical patent/ZA948169B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/38—Eight-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA948169A 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation ZA948169B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP6524026A JPH08500124A (ja) 1993-04-27 1994-04-27 メタロプロテイナーゼインヒビターとしてのペプチジル誘導体
EP94913709A EP0648205B1 (fr) 1993-04-27 1994-04-27 Derives peptidiques inhibiteurs de metalloproteinases
PCT/GB1994/000895 WO1994025434A1 (fr) 1993-04-27 1994-04-27 Derives peptidiques inhibiteurs de metalloproteinases
AU65753/94A AU6575394A (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
AT94913709T ATE182137T1 (de) 1993-04-27 1994-04-27 Peptidylderivate als inhibitoren von metalloproteinase
DE69419473T DE69419473T2 (de) 1993-04-27 1994-04-27 Peptidylderivate als inhibitoren von metalloproteinase
ES94913709T ES2134939T3 (es) 1993-04-27 1994-04-27 Derivados de peptidilo como inhibidores de metaloproteinas.
CA002139128A CA2139128A1 (fr) 1993-04-27 1994-04-27 Derives peptidyle comme inhibiteurs d'une metalloproteinase
US08/356,315 US5714491A (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939308696A GB9308696D0 (en) 1993-04-27 1993-04-27 Peptidyl derivatives
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Publications (1)

Publication Number Publication Date
ZA948169B true ZA948169B (en) 1996-04-18

Family

ID=26302820

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Country Status (10)

Country Link
US (1) US5714491A (fr)
EP (1) EP0648205B1 (fr)
JP (1) JPH08500124A (fr)
AT (1) ATE182137T1 (fr)
AU (1) AU6575394A (fr)
CA (1) CA2139128A1 (fr)
DE (1) DE69419473T2 (fr)
ES (1) ES2134939T3 (fr)
WO (1) WO1994025434A1 (fr)
ZA (1) ZA948169B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
EP0905126B1 (fr) * 1994-01-22 2002-12-04 British Biotech Pharmaceuticals Limited Inhibiteurs de métalloprotéinase
GB2300188B (en) * 1994-01-22 1998-07-01 British Biotech Pharm Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
NZ322553A (en) 1995-11-23 1998-12-23 British Biotech Pharm Metalloproteinase inhibitors
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
ATE225343T1 (de) * 1995-12-20 2002-10-15 Hoffmann La Roche Matrix-metalloprotease inhibitoren
WO1997031892A1 (fr) * 1996-03-01 1997-09-04 Sankyo Company, Limited Derives d'acide hydroxamique
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
WO1997041441A1 (fr) * 1996-04-26 1997-11-06 Children's Medical Center Corporation Depistage d'enzymes noninvasif dans les etats associes au remodelage tissulaire
CZ298048B6 (cs) 1996-09-10 2007-06-06 British Biotech Pharmaceuticals Limited Farmaceutický prostredek a deriváty kyseliny hydroxamové
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US20020099004A1 (en) * 1996-12-06 2002-07-25 Lund Leif Roge Inhibition of invasive remodelling
US5952320A (en) * 1997-01-07 1999-09-14 Abbott Laboratories Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
JP2001513813A (ja) * 1997-03-03 2001-09-04 ダーウィン・ディスカバリー・リミテッド 副作用の少ない選択的ｍｍｐインヒビター
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
GB9707333D0 (en) * 1997-04-11 1997-05-28 British Biotech Pharm Metalloproteinase inhibitors
AU1110799A (en) * 1997-10-29 1999-05-17 Warner-Lambert Company Method of inhibiting metastases of cancer cells
EP1047665B1 (fr) 1998-01-09 2003-10-22 Pfizer Limited Inhibiteurs de metalloproteases matricielles
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
PL357275A1 (en) * 2000-03-21 2004-07-26 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
CA2401728A1 (fr) * 2000-03-21 2001-09-27 The Procter & Gamble Company Inhibiteurs de metalloproteases d'acide difluorobutyrique
SK12842002A3 (sk) * 2000-03-21 2003-02-04 The Procter And Gamble Company Heterocyklický vedľajší reťazec obsahujúci N-substituované inhibítory metaloproteáz a farmaceutický prípravok s ich obsahom
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
CA2446931A1 (fr) 2001-06-15 2002-12-27 Vicuron Pharmaceuticals Inc. Composes bicycliques de pyrrolidine
CN1732023A (zh) * 2002-12-27 2006-02-08 血管技术国际股份公司 组合物和使用collajolie的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
CA2073510A1 (fr) * 1990-12-03 1992-06-04 Celltech Therapeutics Limited Derives peptidyles

Also Published As

Publication number Publication date
JPH08500124A (ja) 1996-01-09
AU6575394A (en) 1994-11-21
US5714491A (en) 1998-02-03
WO1994025434A1 (fr) 1994-11-10
CA2139128A1 (fr) 1994-11-10
EP0648205B1 (fr) 1999-07-14
EP0648205A1 (fr) 1995-04-19
DE69419473T2 (de) 2000-03-16
ATE182137T1 (de) 1999-07-15
ES2134939T3 (es) 1999-10-16
DE69419473D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
ZA948169B (en) Peptidyl derivatives and processes for their preparation
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
MX9709915A (es) Heterociclos de peptidilo y composiciones que los contienen, utiles en el tratamiento de trastornos relacionados con trombina, y uso de los mismos.
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2713500A (en) Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL326700A1 (en) Sulphonamide-based inhibitors of intercellular substance metaloproteinases
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
HU905854D0 (en) New peptidase and isomerase inhibitors
HU9204029D0 (en) Proteolytic enzym inhibitors
PL310475A1 (en) Application of anticonvulsants in treating neuro-aids diseases
EP0793660A4 (fr) 1,1-dioxydes de 1,2,5-thiadiazolidin-3-one substitues en position 2, compositions et procede d'utilisation
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
NZ331484A (en) Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases
ES2109946T3 (es) Nueva forma de sal del 5-difluorometoxi-2-((3,4-dimetoxi-2-piridil)metilsulfinil)-1h-bencimidazol.
BR9917495A (pt) Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
AU8438798A (en) Use of draflazine-analogues for treating pain
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.
ATE179987T1 (de) Vitamin b 12-haltige sanddornkonzentrate oder - extrakte